United Kingdom· GB-APID-38652511000001101
Scenesse 16mg implant
A afamelanotide product containing afamelanotide, registered in United Kingdom by Clinuvel (UK) Ltd. The same ATC class is registered in 10 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Afamelanotide is registered in 10 of 19 countries.
Countries holding a registration under ATC D02BB02 (afamelanotide), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 6 of them publish a price we can compare per daily dose
Afamelanotide · ATC D02BB02
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Afamelanotide
- Manufacturer
- Clinuvel (UK) Ltd
- Country
- United Kingdom (GB)
- ATC code
- D02BB02
- ATC class
- Afamelanotide
- Defined daily dose
- 0.00822 DE, Implantat
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin15056390400007
- gtin05056390400079
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Afamelanotide in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IrelandSCENESSE 16 mg implantClinuvel Europe Limited
- NetherlandsSCENESSE 16 mg, implantaatClinuvel Europe Limited
- BelgiumScenesse 16 mgClinuvel Europe
- CzechiaSCENESSECLINUVEL EUROPE LIMITED, Dublin
- SpainSCENESSE 16 MG IMPLANTEClinuvel (Uk) Limited
- FinlandScenesseClinuvel Europe Limited
- IcelandSCENESSEClinuvel Europe Limited
- PolandScenesseCLINUVEL EUROPE LIMITED
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Scenesse
- Liechtenstein · Scenesse
- Norway · Scenesse
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b2f628fb-aba8-4075-bd64-cb6e92264c3c GET /v1/drugs/b2f628fb-aba8-4075-bd64-cb6e92264c3c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "38652511000001101",
"desc": "Scenesse 16mg implant (Clinuvel (UK) Ltd)",
"form": "Prolonged-release subcutaneous implant",
"vpid": "38726711000001101",
"source": "dmd",
"vtm_id": "822958009",
"strength": "16 mg",
"substance": "Afamelanotide",
"ingredient": "Afamelanotide",
"supplier_code": "38645711000001100"
}See everything about afamelanotide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.